Kolexia
Romano Olivier Oncologie médicale
Romano Olivier
Oncologie médicale
Selarl Groupe D'imagerie Medicale Et De Cancerologie Du Pont Saint Vaast
Lille, France
71 Activités
188 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs de l'oesophage Carcinomes Carcinome épidermoïde Tumeurs colorectales Tumeurs du sein Tumeurs de l'estomac Perte de poids Malnutrition

Collaborateurs

Voir plus
Maes-Dombrowski Patricia
Maes-Dombrowski Patricia
Centre Hospitalier de Lens, Lens, France
Vautravers Dewas Claire
Vautravers Dewas Claire
Centre Hospitalier de Lens, Lens, France
Mensier Eric
Mensier Eric
Cabinet libéral, Marcq-en-Baroeul, France
Briez Nicolas
Briez Nicolas
Hopital Privé Le Bois, Lille, France

Industries

Voir plus
A+A
40 collaboration(s)
Dernière en 2023
B3TSI
20 collaboration(s)
Dernière en 2023
Pierre Fabre
10 collaboration(s)
Dernière en 2023
Sandoz
7 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
283P Patient profiles treated with extended adjuvant neratinib in the early access registry study: NEAR study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study.
2022 ASCO Annual Meeting I   02 juin 2022
Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD.
Journal of geriatric oncology   22 avril 2020
KALICOU3: Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Essai Clinique (Centre Oscar-Lambret)   24 juin 2019
Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018
Sarcopenia and toxicity of the anti-PD1 inhibitors in real-life lung cancer patients: Results from the French Nationwide SCAN study.
2018 ASCO Annual Meeting I   01 juin 2018
NutriCancer: A French observational multicentre cross-sectional study of malnutrition in elderly patients with cancer.
Journal of geriatric oncology   06 septembre 2017
PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Observational study of the cetuximab relative dose intensity (RDI) in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Data on the maintenance and every two weeks use (DIRECT study)
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016
Influence of infusion method on gemcitabine pharmacokinetics: a controlled randomized multicenter trial.
Cancer chemotherapy and pharmacology   21 juillet 2015